Ian O. Ellis

发表

Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesis

I. Ellis, E. Paish, A. Green, 2007, British Journal of Cancer.

Alpha- and beta-adrenergic receptor (AR) protein expression is associated with poor clinical outcome in breast cancer: an immunohistochemical study

I. Ellis, A. Green, H. Habashy, 2011, Breast Cancer Research and Treatment.

Encapsulated papillary carcinoma of the breast: a study of invasion associated markers

I. Ellis, A. Green, E. Rakha, 2012, Journal of Clinical Pathology.

Tumour cell membrane laminin expression is associated with basal-like phenotype and poor survival in Nigerian breast cancer.

I. Ellis, E. Rakha, A. Green, 2016, The Malaysian journal of pathology.

Clinicopathological and molecular significance of Sumolyation marker (ubiquitin conjugating enzyme 9 (UBC9)) expression in breast cancer of black women.

I. Ellis, E. Rakha, A. Green, 2014, Pathology, research and practice.

The localization of pre mRNA splicing factor PRPF38B is a novel prognostic biomarker that may predict survival benefit of trastuzumab in patients with breast cancer overexpressing HER2

G. Ball, I. Ellis, R. Rees, 2017, Oncotarget.

Calpain system protein expression in basal-like and triple-negative invasive breast cancer

I. Ellis, A. Green, R. Macmillan, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Therapeutic Targeting of Integrin αvβ6 in Breast Cancer

Rhian Gabe, Andrew R. Green, Ian O. Ellis, 2014, Journal of the National Cancer Institute.

Long-term (37 years) clinical outcome of older women with early operable primary breast cancer managed in a dedicated clinic.

I. Ellis, A. Green, K. Cheung, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

MicroRNA involvement in the pathogenesis and management of breast cancer

I. Ellis, A. Green, D. Powe, 2009, Journal of Clinical Pathology.

Unravelling transcriptomic complexity in breast cancer through modulation of DARPP-32 expression and signalling pathways

E. Rakha, S. Storr, Behnaz Saidy, 2023, Scientific reports.

Molecular characteristics and prognostic features of breast cancer in Nigerian compared with UK women

I. Ellis, E. Rakha, A. Green, 2012, Breast Cancer Research and Treatment.

Checkpoint kinase1 (CHK1) is an important biomarker in breast cancer having a role in chemotherapy response

I. Ellis, E. Rakha, A. Green, 2015, British Journal of Cancer.

Inflammatory breast cancer: time to standardise diagnosis assessment and management, and for the joining of forces to facilitate effective research

I. Ellis, D. Rea, E. Rakha, 2015, British Journal of Cancer.